Better Therapeutics trading halted, news pending
PremiumThe FlyBetter Therapeutics trading halted, news pending
8M ago
Better Therapeutics Issues Investor Presentation with Cautions
Premium
Company Announcements
Better Therapeutics Issues Investor Presentation with Cautions
8M ago
Better Therapeutics CEO Discusses Future on Bloomberg TV
Premium
Company Announcements
Better Therapeutics CEO Discusses Future on Bloomberg TV
9M ago
Better Therapeutics strengthens financials with amendment to debt, costs
PremiumThe FlyBetter Therapeutics strengthens financials with amendment to debt, costs
12M ago
Better Therapeutics reports Q3 EPS (15c), consensus (21c)
Premium
The Fly
Better Therapeutics reports Q3 EPS (15c), consensus (21c)
1y ago
Better Therapeutics announces topline findings from AspyreRx analysis
Premium
The Fly
Better Therapeutics announces topline findings from AspyreRx analysis
1y ago
Better Therapeutics reports Q2 EPS (24c), consensus (31c)
PremiumThe FlyBetter Therapeutics reports Q2 EPS (24c), consensus (31c)
1y ago
Better Therapeutics issues $6.7M in common stock under its at-the-market program
Premium
The Fly
Better Therapeutics issues $6.7M in common stock under its at-the-market program
1y ago
Better Therapeutics receives FDA authorization for AspyreRx
Premium
The Fly
Better Therapeutics receives FDA authorization for AspyreRx
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100